DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11–20.
CAS PubMed Article Google Scholar
Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol. 2010;2010:214074.
PubMed PubMed Central Google Scholar
Thomas F, Roche B, Ujvari B. Intrinsic versus extrinsic cancer risks: the debate continues. Trends Cancer 2016;2:68–9.
Blundon MA, Dasgupta S. Metabolic dysregulation controls endocrine therapy-resistant cancer recurrence and metastasis. Endocrinology 2019;160:1811–20.
CAS PubMed PubMed Central Article Google Scholar
Mazziotta C, Lanzillotti C, Gafà R, Touzé A, Durand MA, Martini F, et al. The role of histone post-translational modifications in merkel cell carcinoma. Front Oncol. 2022;12:832047.
PubMed PubMed Central Article Google Scholar
Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, et al. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 2011;71:2892–900.
CAS PubMed Article Google Scholar
Kinnaird A, Zhao S, Wellen KE, Michelakis ED. Metabolic control of epigenetics in cancer. Nat Rev Cancer. 2016;16:694–707.
CAS PubMed Article Google Scholar
Campbell SL, Wellen KE. Metabolic signaling to the nucleus in cancer. Mol Cell. 2018;71:398–408.
CAS PubMed Article Google Scholar
Jiang G, Li C, Lu M, Lu K, Li H. Protein lysine crotonylation: past, present, perspective. Cell Death Dis. 2021;12:703.
CAS PubMed PubMed Central Article Google Scholar
Trefely S, Lovell CD, Snyder NW, Wellen KE. Compartmentalised acyl-CoA metabolism and roles in chromatin regulation. Mol Metab. 2020;38:100941.
CAS PubMed PubMed Central Article Google Scholar
Sabari BR, Zhang D, Allis CD, Zhao Y. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 2017;18:90–101.
CAS PubMed Article Google Scholar
Hirschey MD, Zhao Y. Metabolic regulation by lysine malonylation, succinylation, and glutarylation. Mol Cell Proteom. 2015;14:2308–15.
Sreedhar A, Wiese EK, Hitosugi T. Enzymatic and metabolic regulation of lysine succinylation. Genes Dis. 2020;7:166–71.
CAS PubMed Article Google Scholar
Deng L, Meng T, Chen L, Wei W, Wang P. The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal Transduct Target Ther. 2020;5:11.
CAS PubMed PubMed Central Article Google Scholar
Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346–66.
PubMed PubMed Central Article Google Scholar
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol cell Biol. 2005;6:150–66.
CAS PubMed Article Google Scholar
Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19:e46666.
Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.
CAS PubMed Article Google Scholar
Cori CF, Cori GT. The carbohydrate metabolism of tumors II. Changes in the sugar, lactic acid, and CO2-combining power of blood passing through a tumor. J Biol Chem. 1925;65:397–405.
Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2012;2:881–98.
CAS PubMed PubMed Central Article Google Scholar
DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200.
PubMed PubMed Central Article CAS Google Scholar
Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297–308.
CAS PubMed PubMed Central Article Google Scholar
Lee EE, Ma J, Sacharidou A, Mi W, Salato VK, Nguyen N, et al. A protein kinase C phosphorylation motif in GLUT1 affects glucose transport and is mutated in GLUT1 deficiency syndrome. Mol Cell. 2015;58:845–53.
CAS PubMed PubMed Central Article Google Scholar
Siska PJ, Rathmell JC. PKCs sweeten cell metabolism by phosphorylation of Glut1. Mol Cell. 2015;58:711–2.
CAS PubMed PubMed Central Article Google Scholar
Zhang Z, Li X, Yang F, Chen C, Liu P, Ren Y, et al. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis. Nat Commun. 2021;12:5872.
CAS PubMed PubMed Central Article Google Scholar
Du K, Murakami S, Sun Y, Kilpatrick CL, Luscher B. DHHC7 palmitoylates glucose transporter 4 (Glut4) and regulates Glut4 membrane translocation. J Biol Chem. 2017;292:2979–91.
CAS PubMed PubMed Central Article Google Scholar
Jeyaraj S, Boehmer C, Lang F, Palmada M. Role of SGK1 kinase in regulating glucose transport via glucose transporter GLUT4. Biochem Biophys Res Commun. 2007;356:629–35.
CAS PubMed Article Google Scholar
Sun K, Tang S, Hou Y, Xi L, Chen Y, Yin J, et al. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. EBioMedicine 2019;41:370–83.
CAS PubMed PubMed Central Article Google Scholar
Andrisse S, Patel GD, Chen JE, Webber AM, Spears LD, Koehler RM, et al. ATM and GLUT1-S490 phosphorylation regulate GLUT1 mediated transport in skeletal muscle. PLoS ONE. 2013;8:e66027.
CAS PubMed PubMed Central Article Google Scholar
Zhang J, Wang S, Jiang B, Huang L, Ji Z, Li X, et al. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. Nat Commun. 2017;8:13732.
CAS PubMed PubMed Central Article Google Scholar
Yang T, Ren C, Qiao P, Han X, Wang L, Lv S, et al. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer. Oncogene 2018;37:5997–6009.
CAS PubMed PubMed Central Article Google Scholar
Li H, Lu S, Chen Y, Zheng L, Chen L, Ding H, et al. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation. Cell Signal. 2019;58:99–110.
CAS PubMed Article Google Scholar
Li TY, Sun Y, Liang Y, Liu Q, Shi Y, Zhang CS, et al. ULK1/2 constitute a bifurcate node controlling glucose metabolic fluxes in addition to autophagy. Mol Cell. 2016;62:359–70.
CAS PubMed Article Google Scholar
Mathupala SP, Ko YH, Pedersen PL, Hexokinase II. cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006;25:4777–86.
CAS PubMed PubMed Central Article Google Scholar
Hitosugi T, Chen J. Post-translational modifications and the Warburg effect. Oncogene 2014;33:4279–85.
CAS PubMed Article Google Scholar
Lee HJ, Li CF, Ruan D, He J, Montal ED, Lorenz S, et al. Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion. Nat Commun. 2019;10:2625.
PubMed PubMed Central Article CAS Google Scholar
Roberts DJ, Tan-Sah VP, Smith JM, Miyamoto S. Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem. 2013;288:23798–806.
CAS PubMed PubMed Central Article Google Scholar
Shangguan X, He J, Ma Z, Zhang W, Ji Y, Shen K, et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun 2021;12:1812.
CAS PubMed PubMed Central Article Google Scholar
Yi W, Clark PM, Mason DE, Keenan MC,
留言 (0)